Home › Alveolar Soft Part Sarcoma
Alveolar Soft Part Sarcoma clinical trials recruiting in the U.S.
5 studies for Alveolar Soft Part Sarcoma are recruiting participants at sites across the United States.
Recently updated studies
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 23, 2026 · NCT05333458A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Sep 22, 2026 · NCT06066138Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Jun 30, 2026 · NCT06625190A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Apr 23, 2026 · NCT04332874Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT03016819From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.